Publication Type:

Journal Article

Source:

Indian Journal of Radiology and Imaging, Medknow Publications, Volume 25, Number 2, p.184-192 (2015)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84929623155&partnerID=40&md5=b6005c228cd0c1ae957ee9c1c44cbbff

Keywords:

article, bile duct carcinoma, cancer adjuvant therapy, cancer classification, cancer staging, disease predisposition, endoscopic retrograde cholangiopancreatography, hepatojejunostomy, human, liver atrophy, liver transplantation, magnetic resonance cholangiopancreatography, metastasis, multidetector computed tomography, nuclear magnetic resonance imaging, percutaneous transhepatic cholangiography, Photodynamic therapy, preoperative evaluation, radical resection, regional metastasis, Roux Y anastomosis, survival rate

Abstract:

Although hilar cholangiocarcinoma is relatively rare, it can be diagnosed on imaging by identifying its typical pattern. In most cases, the tumor appears to be centered on the right or left hepatic duct with involvement of the ipsilateral portal vein, atrophy of hepatic lobe on that side, and invasion of adjacent liver parenchyma. Multi-detector computed tomography (MDCT) and magnetic resonance cholangiopancreatography (MRCP) are commonly used imaging modalities to assess the longitudinal and horizontal spread of tumor.

Notes:

cited By 0

Cite this Research Publication

M. S. Mahajan, Moorthy, S., Karumathil, S. P., Rajeshkannan, R., and Pothera, R., “Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum”, Indian Journal of Radiology and Imaging, vol. 25, pp. 184-192, 2015.